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Abstract
We conducted a pilot of the Modified Antiretroviral Treatment Access Study (MARTAS), a linkage to HIV treatment intervention,
prior to implementing a multisite randomized controlled trial (RCT) in Ukraine. The objectives of the pilot were to assess the
feasibility and acceptability of the MARTAS intervention among a small sample of adults recently diagnosed with HIV at specialty
clinics in the Mykolaiv region of Ukraine in 2015. The adapted intervention consisted of up to 6 individual-level sessions with a
linkage coordinator (nurse) over a 90-day period. Overall, 22 persons participated in the pilot. On average, participants received
4.2 sessions and 14 participants linked to HIV care within 3 months of study enrollment. All 18 participants who completed the
acceptability survey expressed high satisfaction with their interaction with their linkage coordinator. The results of the pilot
demonstrated feasibility and acceptability of the MARTAS intervention in advance of a larger scale RCT in Ukraine.
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Introduction
Ukraine,with an estimatedHIVprevalence of 0.9% among adults
aged15 to 49years (2015), faces one of the largestHIVepidemics
in Eastern Europe and Central Asia.1 At the end of 2014, an
estimated 223 000 people were living with HIV (PLHIV) in
Ukraine2; only 138 000 (62%) were engaged in HIV care.2 Of
these, 58% had CD4 count below 350  106 cells/L, suggesting
delayed linkage to HIV treatment.3 As of 2015, more than 23 000
people were tested HIV positive in Ukraine,3 and 16 000 (70%)
were linked to HIV care during the year, including individuals
diagnosed either in 2015 or previously. Lack of a case-based
surveillance system in Ukraine makes it difficult to measure
annual linkage-to-care rates among those diagnosed with HIV.3
In 2015, retention in HIV care (determined as at least one clinical
visit during 12months) was 77.7%with only 70% of this propor-
tion receiving antiretroviral therapy (ART).3 Delays in both link-
age to care and ART initiation result in poor treatment outcomes
and further spread of the HIV epidemic.4–6
The most recent estimates (2017) indicate 10 900 PLHIV in
the Mykolaiv region, with 8846 (81%) registered at the AIDS
Center, 7201 (66%) retained in HIV care, and 5692 (52%)
receiving ART. As of 2017, 990 Mykolaiv residents tested HIV
positive and 923 linked to HIV care, although this number
includes individuals who tested HIV positive prior to 2017.7
Again, lack of a case-based surveillance prevents calculation of
linkage to HIV care estimates. Available data suggest an urgent
need to improve linkage to HIV services.8,9
The Antiretroviral Treatment Access Study (ARTAS) is an
individual-level, multisession, time-limited case management
intervention with demonstrated effectiveness in linking persons
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recently diagnosed with HIV to medical care in the United
States.10–12 Antiretroviral Treatment Access Study uses the
strengths-based case management model,13,14 which empowers
participants to apply their internal strengths to achieve life
goals, and is grounded in behavioral theories of empowerment
and self-efficacy.15,16
Linkage to HIV care, our pilot study and randomized con-
trolled trial (RCT) primary outcome, is defined as an initial visit
followed by official registration at the AIDS Center. The process
of registration at the AIDS Center requires a person diagnosed
with HIV to undergo several clinical and laboratory examina-
tions.17 Because of this and other factors specific to the Ukrai-
nian context, the successful transfer of the ARTAS intervention
to a new setting required its adaptation.18 The modifications to
the original ARTAS intervention were made based on formative
research results19 and included intervention delivery at specialty
clinics, called specialized healthcare facilities (SHCFs) in
Ukraine, which provide treatment for infectious diseases, sexu-
ally transmitted infections, and substance abuse. The modified
ARTAS (MARTAS) intervention also included addressing
stigma, fear of HIV status disclosure, depression, and addiction,
based on participant needs, through referrals to psychological,
addiction, and other services. Finally, other modifications
included delivery of the intervention by clinic nurses who per-
formed up to 6 sessions (including up to 3 telephone sessions).
This article describes the results of the pilot study to assess
feasibility and acceptability of MARTAS in a high HIV burden
region of Ukraine prior to the implementation of the interven-
tion in the multisite RCT.2
Methods
All pilot participants were recruited in the Mykolaiv region
between January and April 2015, at 3 urban specialty clinics:
Dermato-Venereological Dispensary, Narcology Dispensary,
and Infectious Diseases Hospital. These clinics typically serve
key populations such as people who inject drugs.
The physicians in each facility informed potential partici-
pants about the study objectives and procedures after HIV
posttest counseling or during their regular clinical visit. Poten-
tially eligible patients of these specialty clinics were referred
by their physicians to the research associates (RAs). Eligibility
criteria included being 18 years or older, recently diagnosed
(tested HIV positive within the past 6 months), fluent in Rus-
sian or Ukrainian, and able to read/understand and sign an
informed consent form. The exclusion criteria were cognitive
impairment, pending legal issues, and being already registered
at the AIDS Center. Physicians in each type of clinic were
given specific instructions on how to refer potentially eligible
patients to the RA. After a patient received information about
the study, the RA approached the patient to confirm eligibility
and they proceeded to a private area where the RA briefly
explained the study aims and procedures. All eligible patients
who agreed to participate were asked to sign the informed
consent form that provided detailed information on all study
procedures, including collection and use of medical and self-
reported information. After providing written informed con-
sent, participants completed an RA-administered, structured
baseline questionnaire.
Upon completion of the baseline questionnaire, the RA
introduced each participant to the linkage coordinator (LC)
to arrange a time for the first in-person intervention session.
Additional MARTAS sessions could be conducted in person
or through the phone. The LCs were allowed to call clients
only from the separate session room, keeping the clients’
phone numbers in a locked cabinet. Linkage coordinators
were nurses who completed a 3-day training on the MARTAS
intervention and the National Institutes of Health online train-
ing “Protecting Human Research Participants.” After comple-
tion of the intervention, clients were scheduled for the
RA-administered 3-month follow-up questionnaire and the
intervention acceptability survey.
Feasibility of the intervention was defined a priori as
achieving outcomes similar to those of the ARTAS effective-
ness trial. For example, we assessed the proportion of the
pilot participants who received at least one session with LC
(participation in the intervention), average number of ses-
sions received by a participant, and proportion of those
linked to HIV care within 3 months (ie, initial visit followed
by official registration at the AIDS Center). We used client
medical records at the AIDS Center as the primary source of
information about participant linkage to HIV care to address
limitations of self-report.11,20 The Mykolaiv (AIDS Center,
personal communication) designated professional with offi-
cial permission to access medical records performed the
review of patient medical charts. Data from the medical chart
What Do We Already Know about This Topic?
Several interventions and promising practices for improv-
ing linkage and maintaining patient engagement in HIV
care were found effective, including strengths-based case
management Antiretroviral Treatment Access Study
(ARTAS) intervention in the United States
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This research describes the results of the study to assess
feasibility and acceptability of the individual-level, multi-
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What Are Your Research’s Implications toward
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MARTAS intervention in the Ukrainian health care
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MARTAS intervention to link HIV-positive adults to
HIV care in Ukraine.
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review were provided by this AIDS Center professional to
the study RAs biweekly.
Acceptability of the MARTAS intervention was measured
using a structured questionnaire that assessed participants’
experience (experience and satisfaction with the intervention),
effective attitude (attitude toward the intervention), and per-
ceived effectiveness (the extent to which the intervention is
perceived as likely to achieve its purpose).
The study protocol, data collection tools, and data security
procedures were approved by the institutional review board at
the Ukrainian Institute on Public Health Policy and the Science
Integrity Branch of the Centers for Disease Control and Pre-
vention (CDC) in Atlanta.
Results
During the pilot, 24 patients at 3 specialty clinics in the Myko-
laiv region were screened for eligibility and 23 consented to
participate in the study. One participant was later excluded
from the study based on the exclusion criteria. Therefore, 22
persons participated in the pilot study. Their mean age was 39.8
years; 13 (59.1%) were male; and most participants (13;
59.1%) were in stable relationships. Nineteen (86.4%) partici-
pants had a high school education or less; 19 (86.4%) were
employed during the past year. Current monthly income of
approximately half of the participants was less than 2000
Ukrainian Hryvnia (equivalent to 77 USD). Nine (40.9%)
Table 1. MARTAS Intervention Indicators at Urban SHCFs in Mykolaiv Region of Ukraine, 2015.
Indicator N/Mean/%
Data from LC reports
Monthly indicator of participant recruitment: 3 new participants per site per
month enrolled in the study
1.9 per site per month
Proportion of the participants who received at least 1 session, of the study
participants who provided informed consent
20/22/91%
Proportion of the participants whose strengths assessment was conducted
at the sessions, of all participants who started participating in the
intervention
20/20/100%
Number of sessions received by participants who completed participation in
the intervention (all sessions, face-to-face sessions, telephone sessions:
average per participant)
Total: 84; 4.2 per participant
Face-to-face sessions: 65; 3.3 per participant
Telephone sessions: 19; 0.95 per participant
Average face-to-face session time (minutes) 62.4 minutes
Average telephone session time (minutes) 22.5 minutes (based on the data of 11 participants)
Number of referrals made—total and average per participant for all
participants who completed participation in the intervention (total,
average per participant)
46 referrals; 2.3 per participant
Proportion of the participants who started intervention and were referred
to the AIDS Center
16/20/80%
Visited the AIDS center among those who started participating in the
intervention
16/20/80%
Of those who visited the AIDS Center: Total: 16 visited
After Session 1 0
After Session 2 6
After Session 3 1
After Session 4 3
After Session 5 6
Data from medical records
Visited the AIDS Center within 3 months after enrollment in the study 16/22/72.7% (of the total number of participants)
Linked to HIV care (completed registration procedure at the AIDS Center) 15/22/68.2% (of the total number of participants)
15/20/75.0% (of those received at least one MARTAS session)
Linked to HIV care within 3 months after enrollment in the study 14/22/63.6% (of the total number of participants)
14/20/70.0% (of those received at least one MARTAS session)
Number of visits to the AIDS Center for those who linked to HIV care













Abbreviations: LC, linkage coordinator; MARTAS, modified ARTAS; SHCFs, specialized healthcare facilities.
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participants reported occasionally not having money for their
basic needs during past year, although all participants reported
having a stable place to live. Twenty of the 22 pilot participants
received at least one MARTAS session (Table 1).
Intervention participants received 4.2 intervention ses-
sions on average (3.3 face-to-face sessions per participant;
0.95 telephone sessions per participant). Average duration
was 62.4 minutes for face-to-face sessions and 22.5 minutes
for telephone sessions. Strengths assessment (the MARTAS
core element) was conducted for each pilot participant dur-
ing the sessions. Each participant, focusing on his or her
self-identified strengths, created an action plan with specific
goals, including linking to HIV medical care. Each partici-
pant received on average 2.3 referrals to the AIDS Center,
addiction treatment, psychological services, and nongovern-
mental organizations.
Review of the participants’ medical charts at the AIDS Cen-
ter showed that 14 participants completed the registration pro-
cedure at the AIDS Center within 3-month period, having made
on average 3.3 clinical visits to the AIDS Center.
Overall, 18 participants who received at least one MARTAS
session completed the acceptability survey (Table 2). All 18
were satisfied with the LC-delivered intervention sessions, and
16 considered their LC as knowledgeable about HIV. Fifteen
participants positively assessed the intervention and the role of
the LC in their linkage to HIV medical care. Finally, all respon-
dents thought that LCs would be useful in helping others link to
HIV care in the future.
Discussion
The study results demonstrated both feasibility and acceptabil-
ity of the MARTAS intervention to improve linkage to HIV
care for adults recently diagnosed with HIV in SHCFs.
The first case management session was mostly delivered on
the day of the participant baseline interview and after his or her
in-person meeting with the LC. This modification of ARTAS,
along with the delivery of the intervention by a regular clinical
staff member (a nurse), ensured the intervention feasibility,
reflected by a high uptake of the intervention (20 of 22, or
90.9% of the pilot participants attended MARTAS sessions).
The average number of intervention sessions per participant
(both face-to-face and telephone; mean 4.2, median 4.5) was
higher compared to the number of face-to-face sessions parti-
cipants received in the US-based ARTAS-II study (mean 2.3
and median 2 sessions).11
In our pilot study, the proportion of those linked to HIV
care (70% among those who received MARTAS and 63.6%
among all study participants) was lower compared to the
ARTAS results (78% of the intervention participants).10 This
difference may be attributed to a complex, time-consuming
process of registration at the AIDS Center in Ukraine.21
Lower linkage to HIV care may also be a result of inconsistent
outcome definitions across the 2 studies: in the MARTAS
pilot study, the main outcome was defined as “completed
registration at the AIDS Center within a 3-month period,”
Table 2. MARTAS Intervention Acceptability Indicators at Urban
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Abbreviations: LC, linkage coordinator; MARTAS, modified ARTAS; NA, no
answer; SHCFs, specialized healthcare facilities.
aData from one participant who reported 20 meetings with an LC has been
excluded from the analysis; based on LC report, the total number of session
with this participant was 6, other meetings with LC reported by the participant
assumed were not related to MARTAS sessions and may happen during regular
clinical visits of participant to SHCF.
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while in ARTAS it was “at least one visit to an HIV clinician
within a 6-month period.”
Study follow-up among participants who completed the 3-
month interview—19 (86.4%)—was comparablewith theARTAS
follow-up rate (86%).10 The high level of participants’ satisfaction
with their meetings with the LC and their opinion of their LC as
knowledgeable about HIV confirms sufficient trust of the patients
to the information delivered by healthcare providers, which justi-
fies the proposed delivery of the intervention by nurses.
The ARTAS intervention has been adapted and implemented
in several studies in different countries and populations.22–24
One of the main modifications to the ARTAS in our study was
delivery of the intervention not in community but in clinical
settings.10 Such approach fits well to the Ukrainian concentrated
HIV epidemic25 where key populations often seek medical care
at specialty clinics. Referrals to psychological, addiction, and
other services addressed the specific needs of key populations
with HIV and multiple comorbidities.8,26
The study had certain limitations. Modified ARTAS was
conducted at the clinical sites located in one region of Ukraine,
so the results may not be generalizable to other settings. How-
ever, the centralized healthcare infrastructure makes this lim-
itation less significant.
Conclusion
Findings from this pilot study of the MARTAS intervention
demonstrate the feasibility and acceptability of the proposed
case management MARTAS intervention for adults recently
diagnosed with HIV in selected specialty clinics. The results
provide the rationale for a large-scale RCT to assess the effec-
tiveness of the MARTAS intervention to link HIV-positive
adults to HIV care in Ukraine.
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